BS ISO 29943-2:2017
$189.07
Condoms. Guidance on clinical studies – Female condoms, clinical function studies based on self-reports
Published By | Publication Date | Number of Pages |
BSI | 2017 | 50 |
PDF Catalog
PDF Pages | PDF Title |
---|---|
2 | National foreword |
7 | Foreword |
8 | Introduction |
9 | 1 Scope 2 Normative references 3 Terms and definitions |
11 | 4 Risk assessment 5 Pilot clinical studies |
12 | 6 Clinical validation investigation 6.1 Objectives of clinical validation investigation 6.2 Outcome measures 6.3 Study subjects 6.3.1 General |
13 | 6.3.2 Enrolment of study subjects |
14 | 6.4 Informed consent 6.5 Test and control condoms 6.5.1 General |
15 | 6.5.2 Test condom 6.5.3 Control condom 6.5.4 Trial duration exceeds one year |
16 | 6.5.5 Sampling of control condoms for bench testing 6.6 Randomization 6.7 Allocation concealment and study masking 6.8 Use of additional lubricant 6.9 Instructions and interactions with study couples |
17 | 6.10 Interviews and data collection 6.10.1 Schedule for interviews and condom distribution 6.10.2 Enrolment interview |
18 | 6.10.3 Individual condom use CRF 6.10.4 Mid-study CRF, crossover trial |
19 | 6.10.5 Compiling data from CRFs 6.11 Data integrity 6.11.1 General 6.11.2 Interactive voice response systems (IVRS) 6.11.3 Mail-in and web-based data reporting |
20 | 6.11.4 Web-based data collection systems, additional suggestions |
21 | 6.12 Control of distribution chain 6.13 Analysis of returned condoms 6.14 Other methodological details |
22 | 6.15 Statistical analysis plan 6.15.1 General 6.15.2 Primary study hypothesis |
23 | 6.15.3 Secondary study hypotheses 6.15.4 Study design 6.15.5 Statistical analysis |
24 | 6.15.6 Additional statistical comments and concerns 6.16 Clinical study results: Review and interpretation 6.16.1 General 6.16.2 Total clinical failure rates for control condom 6.16.3 Non-inferiority |
25 | 6.16.4 Superiority 6.16.5 Safety (adverse events) 6.16.6 What happens if one is unable to conclude non-inferiority? |
26 | Annex A (informative) Formula for power calculation |
27 | Annex B (informative) Pilot clinical investigation (sample outline) |
29 | Annex C (informative) Time and events schedule for individual study subject (sample) |
30 | Annex D (informative) CRF — Study entry (sample) |
33 | Annex E (informative) CRF — Mid-study (sample) |
35 | Annex F (informative) CRF — Single use of female condom (sample) |
39 | Annex G (informative) CRF — Adverse event (sample) |
41 | Annex H (informative) Protocol for evaluation of returned used condoms |
47 | Bibliography |